SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

JP Morgan Downgrades Frequency Therapeutics to Neutral, Announces $27 Price Target

JP Morgan analyst Anupam Rama downgrades Frequency Therapeutics (NASDAQ:FREQ) from Overweight to Neutral and announces $27 price target.

Benzinga · 05/18/2020 11:03

JP Morgan analyst Anupam Rama downgrades Frequency Therapeutics (NASDAQ:FREQ) from Overweight to Neutral and announces $27 price target.